READ › "Are Safety Signals Overlooked in Clinical Trials?" By Moe Alsumidaie, APPLIED CLINICAL TRIALS. Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.
READ › Rare Disease Day is February 28th, and ARG is planning to participate in several ways. Locally, we are planning to recognize rare disease and do something as a group to make a tangible impact. We also stand together with rare disease stakeholders from all around the world; please see: https://www.rarediseaseday.org/
READ › Register today to join Marilee Newman and Michael Lange on November 15 @ 1PM EST for a webinar on "Query Quality Review for Todays Clinical Trials" hosted by Medrio, a leading EDC technology provider.
READ › Prometic announces FDA acceptance of its Biologics License Application (BLA) for its plasminogen replacement therapy (RyplazimTM).
READ › Atlantic Research Group forms Rare Disease Strategic Advisory Board to accelerate novel medicines. Learn about this collaboration between patient advocacy groups, government institutions, and drug developers to address challenges in rare disease.
READ › ARG's work philosophy on why "CRA-centricity" matters for your rare disease clinical trial in Applied Clinical Trials
READ › ARG to attend the BIO International Convention from 19-22 June 2017 in San Diego, CA.
READ › Come see our speakers at MAGI East 2017! John Boland, VP of Product Development will be speaking about "Managing Clinical Projects Across Organizations" and Erin Farris, Director of Project Management will be discussing "Clinical Project Management: Best Practices Working Group". We look forward to seeing you in Philadelphia!
READ › ARG supports Rare Disease Day 2017! At ARG we believe Everyone is rare, for a reason. We dedicate ourselves to improving the lives of those battling rare diseases, because everyone deserves to be well.
READ › ARG to attend the CIS (Clinical Immunology Society) Immune Deficiency & Dysregulation North American Conference in Seattle, WA on March 23-26, 2017
READ › Come see us at the SCOPE Summit 2017 in Miami, January 24-26! ARG will be hosting a hospitality suite in the Board Room of the Hyatt Regency, and will be featured throughout the event. Our VP of Product Development, John Boland, will be chairing sessions on Clinical Trial Forecasting and Budgeting, Establishing and Outsourcing Strategy, and Managing Outsourced Clinical Trials. We look forward to seeing you in Miami!
READ › Barry Herndon, Lead CRA with Atlantic Research Group, is a member of the planning committee for the Central Virginia Chapter of ACRP's Fall Symposium. This year's event, held on November 18th, is a day long event, with 7.25 contact hours available, and will host an exciting variety of workshops relevant to the clinical research field, led by top notch speakers.
READ › Atlantic Research Group's Lead CRA, Gina Gualtiere, is part of the planning committee for ACRP's New York Metropolitan Chapter's Fall Symposium. The chapter will host a full day of education material for clinical research professionals on November 4, 2016 at The Manhattan Club at Rosie O'Grady's in NYC.
READ › Atlantic Research Group's Director of Project Management, John Boland along with Joanna Murray, Project Director, will be presenting at this year's MAGI's Clinical Research Conference 2016 West. All sessions will be held at Planet Hollywood Resort, Las Vegas Nevada October 23-26. For more information email: email@example.com
READ › Atlantic Research Group to attend the NORD (National Organization for Rare Disorders) Rare and Orphan Products Breakthrough Summit in Arlington, VA October 17-18 2016.
READ › Atlantic Research Group Chief Scientific Officer, Bryce Warren (SoCRA Scientific Programs Chairman) to moderate the SoCRA special recognition award and evaluation competition at the 2016 SoCRA Annual Meeting in Montreal Canada, September 30 - October 2nd.
READ › Atlantic Research Group Hires Vice President of Finance
READ › Atlantic Research Group Hires Director of Data Management
READ › Atlantic Research Group Launches Drug Safety Services Program (PDF-41K)
READ › Atlantic Research Group Chief Science Officer Joins Histiocytosis Association Board of Trustees (PDF-45K)
READ › Atlantic Research Group Initiates ProMetic Life Sciences Phase III Intravenous Immunoglobulin (IVIG) Trial in Patients with Primary Immune Disease (PID) (PDF-34K)
READ › Atlantic Research Group Manages Our Trials More Effectively with Quickbase (PDF-699K)
READ › Atlantic Research Group Implements Veevas Vault eTMF (PDF-43K)
READ › Atlantic Research Group Initiates Cellectar Biosciences Phase I Study (PDF-35K)
READ › Atlantic Research Group Implements ArisGlobal (PDF-36K)
READ › ARG and Comprehend Clinical - A Shared Strategic Vision for Technology in Clinical Research
READ › Atlantic Research Group moves forward with Comprehend Clinical
READ › Atlantic Research Group Selects Comprehend Clinical
READ › Atlantic Research Group client Kinex Pharmaceuticals Initiates Phase I Glioblastoma trial
READ › Comprehend is used by Atlantic Research Group to increase ROI for internal operations and to provide Sponsors self-service clinical data analytics.
READ › Atlantic Research Group CTO to Speak on Enhanced Reporting Tools
READ › Atlantic Research Group (ARG) managed the pivotal clinical trials for Chelsea Therapeutics NORTHERA (droxidopa) which has won FDA approval
READ › Green Cross Corp. presents IVIG SN data at AAAAI Annual Meeting - ARG managed Phase III trial
READ › Atlantic Research Group locks database of Phase III IVIG Study (PDF-221K)
READ › Atlantic Research Group is Awarded Phase III Intravenous Immunoglobulin Study (PDF-231K)
READ › Atlantic Research Group is Awarded Pivotal Phase III IVIG Study
READ › Atlantic Research Group selects OpenClinica Enterprise as its EDC platform
READ › Small to mid-tier biopharm may be deserting large CROs
READ › Atlantic Research Group client, Chelsea Therapeutics, reports positive Phase III results
READ › Atlantic Research Group Successfully Rescues Pivotal Phase III Program in Neurogenic Orthostatic Hypotension (NOH)
READ › Atlantic Research Group and The Pharmaceutical Service Network (PSN) are featured on ClinPage
READ › Atlantic Research Group Joins The Pharmaceutical Service Network (PSN)
READ › TrialVista® Platform Wins Best of SaaS Showplace Award
READ › Atlantic Research Group's CTMS featured on ClinPage
READ › Atlantic Research Group client, Chelsea Therapeutics, reports positive Phase II results
READ › Atlantic Research Group Client, Lev Pharmaceuticals, is Granted FDA Approval for Cinryze (TM)
READ › Atlantic Research Group and TrialVista are featured in Datamonitor: "In Pursuit of the Paperless Clinical Trial: A Look at EDC and CTMS."
#biopharma twtr feedTweets about "#biopharma"